Page 134 - Haematologica-April 2018

A. Arvidsson et al.
al. STRING v10: protein-protein interaction
networks, integrated over the tree of life. Nucleic Acids Res. 2015;43(Database issue):D447-452.
29. Edgar R, Domrachev M, Lash AE. Gene Expression Omnibus: NCBI gene expres- sion and hybridization array data reposito- ry. Nucleic Acids Res. 2002;30(1):207-210.
30. Herishanu Y, Perez-Galan P, Liu D, et al. The lymph node microenvironment pro- motes B-cell receptor signaling, NF-kappaB activation, and tumor proliferation in chronic lymphocytic leukemia. Blood. 2011;117(2):563-574.
31. Saba NS, Liu D, Herman SE, et al. Pathogenic role of B-cell receptor signaling and canonical NF-kappaB activation in mantle cell lymphoma. Blood. 2016;128(1):82-92.
32. Sivina M, Hartmann E, Vasyutina E, et al. Stromal cells modulate TCL1 expression, interacting AP-1 components and TCL1- targeting micro-RNAs in chronic lympho- cytic leukemia. Leukemia. 2012;26(8):1812- 1820.
33. Naba A, Clauser KR, Hoersch S, et al. The matrisome: in silico definition and in vivo characterization by proteomics of normal and tumor extracellular matrices. Mol Cell Proteomics. 2012;11(4):M111 014647.
34. Mittal AK, Chaturvedi NK, Rai KJ, et al. Chronic lymphocytic leukemia cells in a lymph node microenvironment depict molecular signature associated with an aggressive disease. Mol Med. 2014;20(290- 301.
35. Ghobrial IM, Bone ND, Stenson MJ, et al. Expression of the chemokine receptors CXCR4 and CCR7 and disease progression in B-cell chronic lymphocytic leukemia/
small lymphocytic lymphoma. Mayo Clin
Proc. 2004;79(3):318-325.
36. Purroy N, Abrisqueta P, Carabia J, et al. Co-
culture of primary CLL cells with bone marrow mesenchymal cells, CD40 ligand and CpG ODN promotes proliferation of chemoresistant CLL cells phenotypically comparable to those proliferating in vivo. Oncotarget. 2015;6(10):7632-7643.
37. Chiron D, Bellanger C, Papin A, et al. Rational targeted therapies to overcome microenvironment-dependent expansion of mantle cell lymphoma. Blood. 2016;128(24):2808-2818.
38. Vogler M, Butterworth M, Majid A, et al. Concurrent up-regulation of BCL-XL and BCL2A1 induces approximately 1000-fold resistance to ABT-737 in chronic lympho- cytic leukemia. Blood. 2009;113(18):4403- 4413.
39. Bystry RS, Aluvihare V, Welch KA, Kallikourdis M, Betz AG. B cells and pro- fessional APCs recruit regulatory T cells via CCL4. Nat Immunol. 2001;2(12):1126- 1132.
40. Nygren L, Wasik AM, Baumgartner- Wennerholm S, et al. T-cell levels are prog- nostic in mantle cell lymphoma. Clin Cancer Res. 2014;20(23):6096-6104.
41. Takahashi K, Sivina M, Oki Y, et al. Serum CCL3 and CCL4 Levels Function As Novel Prognostic Markers in Diffuse Large B Cell Lymphoma. Blood. 2012;120(21):2.
42. Sivina M, Hartmann E, Kipps TJ, et al. CCL3 (MIP-1alpha) plasma levels and the risk for disease progression in chronic lym- phocytic leukemia. Blood. 2011; 117(5):1662-1669.
43. Beguelin W, Sawh S, Chambwe N, et al. IL10 receptor is a novel therapeutic target
in DLBCLs. Leukemia. 2015;29(8):1684-
1694.
44. Baran-Marszak F, Boukhiar M, Harel S, et
al. Constitutive and B-cell receptor-induced activation of STAT3 are important signaling pathways targeted by bortezomib in leukemic mantle cell lymphoma. Haematologica. 2010;95(11):1865-1872.
45. Lech-Maranda E, Bienvenu J, Broussais- Guillaumot F, et al. Plasma TNF-alpha and IL-10 Level-Based Prognostic Model Predicts Outcome of Patients with Diffuse Large B-Cell Lymphoma in Different Risk Groups Defined by the International Prognostic Index. Arch Immunol Ther Exp. 2010;58(2):131-141.
46. DiLillo DJ, Weinberg JB, Yoshizaki A, et al. Chronic lymphocytic leukemia and regula- tory B cells share IL-10 competence and immunosuppressive function. Leukemia. 2013;27(1):170-182.
47. Ezell SA, Mayo M, Bihani T, et al. Synergistic induction of apoptosis by com- bination of BTK and dual mTORC1/2 inhibitors in diffuse large B cell lymphoma. Oncotarget. 2014;5(13):4990-5001.
48. Guilloton F, Caron G, Menard C, et al. Mesenchymal stromal cells orchestrate fol- licular lymphoma cell niche through the CCL2-dependent recruitment and polariza- tion of monocytes. Blood. 2012; 119(11):2556-2567.
49. Xuan W, Qu Q, Zheng B, Xiong S, Fan GH. The chemotaxis of M1 and M2 macrophages is regulated by different chemokines. J Leukoc Biol. 2015;97(1):61- 69.
50. Staudt LM. Oncogenic Activation of NF- kappa B. Cold Spring Harbor Perspect Biol. 2010;2(6):30.
678
haematologica | 2018; 103(4)